From John Money to Modern Gender Clinics: An Insider Speaks - Dr. Quentin Van Meter (#28)

11 August 2025

With Dr. Quentin Van Meter

65 minutes

Paediatric endocrinologist Dr. Quentin Van Meter was not an observer of gender medicine's rise—he was inside it, training at Johns Hopkins during the John Money era and treating gender-distressed children before any clinical guidelines existed. In this episode, Stella O'Malley, Mia Hughes and Dr. Bret Alderman draw him out on four decades of medical practice, the transformation of WPATH, contested claims about puberty blockers, and what finally drove him to leave the American Academy of Pediatrics. A long view from someone who was there.

Very few guests that Stella O'Malley, Mia Hughes and Dr. Bret Alderman have spoken with carry the kind of first-hand institutional knowledge that Dr. Quentin Van Meter brings to this episode. A paediatric endocrinologist with more than forty years of clinical practice, Van Meter was not an outside critic of gender medicine's rise—he was inside it, treating his first gender-distressed child in 1993 before any formal protocols existed, and training at Johns Hopkins during a period that would prove foundational to the entire field. The conversation spends considerable time on Van Meter's direct encounter with John Money at Hopkins. Money's theories about psychological sex assignment—later discredited and linked to cases of serious harm—became embedded in the later gender-affirming model. Van Meter's account of that clinical environment, including a specific incident involving an infant, gives the discussion a texture that second-hand histories cannot replicate. Stella, Mia and Bret are attentive interviewers here, drawing the detail out rather than simply accepting the headline. From Hopkins the conversation traces the institutional story forward: how the World Professional Association for Transgender Health evolved from a marginal specialist body into an organisation whose standards carry significant clinical and legal weight across many countries. Van Meter's position is that this expansion outpaced its scientific basis. He has held this view publicly since his 2018 lecture on what he described as the fraud of transgender medicine, but the podcast format gives the argument a more conversational texture—shaped by the hosts' questions and, at times, their genuine curiosity about how a clinician who once worked within this field arrived at such a firm conclusion. The episode also moves through several of the most contested empirical claims in current gender medicine: what the evidence actually says about cognitive risks associated with puberty-blocking medications, the proportion of children who begin blockers and proceed to cross-sex hormones, and what it means for a child when distress is met primarily with a medical pathway. Van Meter answers from four decades of endocrinology practice rather than from advocacy, which gives even his more pointed assertions a clinical grounding that listeners can weigh for themselves. One of the quieter revelations concerns Van Meter's departure from the American Academy of Pediatrics after nearly four decades—a decision he ties directly to the organisation's position on transgender care, which he regards as having been manufactured rather than derived from evidence. It is a detail that resonates with a question the Beyond Gender podcast has examined from many directions: what happens to clinicians who dissent publicly, and what institutional pressures determine what can be said? This is not a comfortable listen, and the hosts do not frame it as one. It is, however, a serious conversation with a senior clinician who was present at formative moments of paediatric gender medicine. For listeners trying to understand how the current landscape came to be—not just its policies but the assumptions that gave rise to them—Van Meter's long view, offered here in dialogue rather than polemic, is a genuinely valuable hour.

More recent episodes